Kipp Weiskopf, MD, PhD

445 posts

Kipp Weiskopf, MD, PhD

@KippWeiskopf

Whitehead Fellow @WhiteheadInst | Hematology & Oncology Fellow @DanaFarber | cancer immunotherapy researcher | macrophage enthusiast

Boston, MA Katılım Kasım 2013

354 Takip Edilen746 Takipçiler

Kipp Weiskopf, MD, PhD retweetledi

BIDMC Cancer Center@BIDMC_CancerCtr·22 Nis

#AACR26 spotlight: Carlota Pages-Geli, PhD, @KippWeiskopf lab, “Unbiased discovery of novel microphage-activating immunotherapies for ALK+ #NSCLC.” 💡Combining CD47 x TROP2 bispecific antibodies with lorlatinib produced synergistic anti-tumor effects. #LungCancer

English

343

Kipp Weiskopf, MD, PhD@KippWeiskopf·18 Kas

To learn more about our lab's work at @WhiteheadInst, please visit us here: weiskopf-lab.org @kochinstitute @DanaFarberNews @MITBiology @MIT

English

244

Kipp Weiskopf, MD, PhD@KippWeiskopf·18 Kas

In the future, we are excited to apply this same approach to other types of cancer to rapidly generate new, transformative therapies for patients. We are thankful to funding sources to support this work, including the @ValhallaFound and @AACR

English

348

Kipp Weiskopf, MD, PhD@KippWeiskopf·18 Kas

We are excited to share a new study describing a novel strategy to rapidly produce, test, and validate bispecific antibodies for lymphoma! This work was led by Juliano Ribeiro and @CarlotaPGeli in collaboration with the lab of @MartaCrespoHEM #lymsm biorxiv.org/content/10.110…

English

1.6K

Kipp Weiskopf, MD, PhD@KippWeiskopf·9 Eki

Congratulations to former @WhiteheadInst postdoc, Dian Yang, on your @NIH New Innovator Award! @dianyang1117

NIH Common Fund@NIH_CommonFund

Early-stage investigators proposed #innovative high-impact research ideas for the @NIHDirector’s New Innovator Award. See the projects the awardees will pursue: commonfund.nih.gov/newinnovator/A… #NIHHighRisk

English

975

Kipp Weiskopf, MD, PhD@KippWeiskopf·9 Eki

@weldeiry @WhiteheadInst @AACR Great to meet you too!

English

349

Wafik S. El-Deiry, MD, PhD, FACP@weldeiry·8 Eki

Great to meet physician-scientist oncologist Kipp Weiskopf at @WhiteheadInst and hear about his interest in innate immune TRAIL pathway in the TME. Exciting directions. @AACR @KippWeiskopf

Wafik S. El-Deiry, MD, PhD, FACP tweet media

English

541

Kipp Weiskopf, MD, PhD@KippWeiskopf·28 Ağu

Thank you, @brendaraud and @DrSifuJG for hosting me on the @ImmunoPodcast! I enjoyed our discussion on targeting myeloid cells in the tumor microenvironment!

Immunology Podcast@ImmunoPodcast

Today's episode focuses on #macrophages! Listen to Dr. @KippWeiskopf from the @WhiteheadInst talk about macrophages in the tumor environment and how targeting the #CD47/SIRPa axis can induce phagocytosis of cancer cells. 🎧: bit.ly/4dXk0g4

English

1.9K

Kipp Weiskopf, MD, PhD@KippWeiskopf·27 Ağu

We are excited to share our lab's new website! @WhiteheadInst @kochinstitute weiskopf-lab.org

English

3.7K

Kipp Weiskopf, MD, PhD retweetledi

Journal of Clinical Investigation@jclinicalinvest·9 May

#Commentary: Enhancing anticancer activity of macrophages through rational drug combinations: buff.ly/3wltsty @OHSUKnight @_CRCHUS Related article: buff.ly/3UuauZR

Journal of Clinical Investigation tweet media

English

Kipp Weiskopf, MD, PhD@KippWeiskopf·6 May

We are excited to share work from our lab @WhiteheadInst describing new strategies to provoke macrophages to attack and eliminate lung cancer! We hope these findings will inspire new clinical trials for patients with lung cancers bearing driver mutations @DanaFarber @theNCI #lcsm

Journal of Clinical Investigation@jclinicalinvest

Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction: buff.ly/3UuauZR @KippWeiskopf @WhiteheadInst @DanaFarber #Oncology #Therapeutics

English

6.2K

Kipp Weiskopf, MD, PhD retweetledi

Science in Boston@ScienceinBoston·20 Nis

Researchers from the @WhiteheadInst and @MGHCancerCenter have developed a novel screening platform to identify drugs that render #LungCancer cells more vulnerable to macrophage attack. Read more in @jclinicalinvest: bit.ly/4aKp6LE

English

1.3K

Kipp Weiskopf, MD, PhD@KippWeiskopf·16 Nis

Thanks for sharing our work on macrophage immunotherapy! We hope it makes a difference to patients with cancers bearing driver mutations! @DanaFarberNews @MGHCancerCenter #lcsm @EGFRResisters @ALKPositiveinc @KRASKickers @ABOHLung @theNCI @LungAssociation @AACR @jclinicalinvest

Whitehead Institute@WhiteheadInst

A novel drug screen developed by @KippWeiskopf and the Hata lab at MGH identifies existing drugs that can help prime lung cancer cells for destruction by macrophages: wi.mit.edu/news/targeted-…

English

3.3K

Kipp Weiskopf, MD, PhD@KippWeiskopf·9 Kas

A great profile of physician-scientist @asaf_maoz, who is advancing the frontier of cancer therapy and cancer care. We are excited for many more discoveries! @WhiteheadInst @DanaFarber @DanaFarberNews

Whitehead Institute@WhiteheadInst

Asaf Maoz is a postdoc studying new immunotherapy strategies to treat cancer, as well as a clinical fellow at @DanaFarber. In our latest #WhiteheadPostdocProfiles, we sat down with Asaf to learn more his experiences in and out of the lab: wi.mit.edu/news/meet-whit…

English

3.8K

Kipp Weiskopf, MD, PhD@KippWeiskopf·20 Eki

Congratulations, @dianyang1117! Definitely a great opportunity for anyone looking to join a lab in New York!

Dian Yang@dianyang1117

Excited to announce the Yang lab officially opens at @Columbia University. We are interested in developing innovative single cell recording technologies to study tumor evolution and cancer plasticity. We are hiring motivated postdocs & students, please RT dianyanglab.com

English

863

Kipp Weiskopf, MD, PhD retweetledi